- Texier C, Pouvelle S, Busson M, Herve M, Charron D, Menez A, Maillere B:
HLA-DR restricted peptide candidates for bee venom immunotherapy. J Immunol
2000, 164(6):3177-3184 (PMID: 10706708
)
- Mandic M, Almunia C, Vicel S, Gillet D, Janjic B, Coval K, Maillere B, Kirkwood
JM, Zarour HM: The alternative open reading frame of LAGE-1 gives rise to
multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type
tumor-reactive CD4+ T cells. Cancer research 2003, 63(19):6506-6515 (PMID:
14559844)
- Immonen A, Farci S, Taivainen A, Partanen J, Pouvelle-Moratille S, Narvanen
A, Kinnunen T, Saarelainen S, Rytkonen-Nissinen M, Maillere B et al: T cell
epitope-containing peptides of the major dog allergen Can f 1 as candidates
for allergen immunotherapy. J Immunol 2005, 175(6):3614-3620 (PMID: 16148105)
- Gahery H, Figueiredo S, Texier C, Pouvelle-Moratille S, Ourth L, Igea C,
Surenaud M, Guillet JG, Maillere B: HLA-DR-restricted peptides identified
in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting
CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination. AIDS
research and human retroviruses 2007, 23(3):427-437 (PMID: 17411376)